BASELINE/EARLY PRESENCE OF KNOWN AND NOVEL RESISTANCE MUTATIONS IS ASSOCIATED WITH VIRAL FAILURE IN DIFFICULT-TO-TREAT PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORS

Cento V;Di Maio VC;Di Paolo D;Micheli V;Tontodonati M;De Leonardis F;Aragri M;Antonucci FP;Mancon A;Armenia D;Bellocchi MC;Lenci I;Manunta A;Taliani G;Di Biagio A;Nicolini LA;Nosotti L;Sarrecchia C;Siciliano M;Landonio S;Pellicelli A;Gasbarrini A;Vecchiet J;Magni CF;Babudieri S;Mura MS;Andreoni M;Parruti G;Rizzardini G;Angelico M;Perno CF;Ceccherini-Silberstein F

2014-01-01